Compare TCOM & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCOM | GEHC |
|---|---|---|
| Founded | 1999 | 1892 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.9B | 33.1B |
| IPO Year | 2003 | N/A |
| Metric | TCOM | GEHC |
|---|---|---|
| Price | $70.87 | $82.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $80.00 | ★ $86.67 |
| AVG Volume (30 Days) | 2.2M | ★ 4.2M |
| Earning Date | 11-17-2025 | 10-29-2025 |
| Dividend Yield | ★ 0.42% | 0.17% |
| EPS Growth | ★ 86.40 | 32.35 |
| EPS | ★ 6.25 | 4.83 |
| Revenue | $8,393,499,281.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $18.22 | $6.33 |
| Revenue Next Year | $13.73 | $4.38 |
| P/E Ratio | ★ $11.33 | $17.38 |
| Revenue Growth | ★ 17.45 | 3.51 |
| 52 Week Low | $51.35 | $57.65 |
| 52 Week High | $78.65 | $94.80 |
| Indicator | TCOM | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 55.27 |
| Support Level | $69.86 | $83.56 |
| Resistance Level | $72.07 | $86.19 |
| Average True Range (ATR) | 1.03 | 2.12 |
| MACD | 0.09 | 0.09 |
| Stochastic Oscillator | 62.12 | 44.23 |
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).